CN114618006B - Intelligent wound dressing, preparation method and application thereof, and flexible sensor - Google Patents
Intelligent wound dressing, preparation method and application thereof, and flexible sensor Download PDFInfo
- Publication number
- CN114618006B CN114618006B CN202210371111.8A CN202210371111A CN114618006B CN 114618006 B CN114618006 B CN 114618006B CN 202210371111 A CN202210371111 A CN 202210371111A CN 114618006 B CN114618006 B CN 114618006B
- Authority
- CN
- China
- Prior art keywords
- wound dressing
- intelligent
- flexible sensor
- thermoplastic elastomer
- citric acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 238000002360 preparation method Methods 0.000 title abstract description 15
- 239000002346 layers by function Substances 0.000 claims abstract description 45
- 239000002131 composite material Substances 0.000 claims abstract description 35
- 239000002121 nanofiber Substances 0.000 claims abstract description 32
- 239000012528 membrane Substances 0.000 claims abstract description 31
- 229920002635 polyurethane Polymers 0.000 claims abstract description 27
- 239000004814 polyurethane Substances 0.000 claims abstract description 27
- 229920002725 thermoplastic elastomer Polymers 0.000 claims abstract description 27
- 239000000758 substrate Substances 0.000 claims abstract description 20
- 229920001661 Chitosan Polymers 0.000 claims abstract description 15
- 230000002439 hemostatic effect Effects 0.000 claims abstract description 14
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims description 138
- 239000010410 layer Substances 0.000 claims description 23
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 claims description 21
- 238000009987 spinning Methods 0.000 claims description 20
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 claims description 14
- 238000010041 electrostatic spinning Methods 0.000 claims description 11
- 238000002156 mixing Methods 0.000 claims description 10
- 238000012544 monitoring process Methods 0.000 claims description 10
- 239000002904 solvent Substances 0.000 claims description 8
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 claims description 7
- 238000004519 manufacturing process Methods 0.000 claims description 2
- 230000004043 responsiveness Effects 0.000 abstract description 2
- 206010052428 Wound Diseases 0.000 description 77
- 208000027418 Wounds and injury Diseases 0.000 description 73
- PXRKCOCTEMYUEG-UHFFFAOYSA-N 5-aminoisoindole-1,3-dione Chemical compound NC1=CC=C2C(=O)NC(=O)C2=C1 PXRKCOCTEMYUEG-UHFFFAOYSA-N 0.000 description 42
- 238000012360 testing method Methods 0.000 description 22
- 230000000052 comparative effect Effects 0.000 description 17
- 239000000243 solution Substances 0.000 description 13
- 230000004044 response Effects 0.000 description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 11
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 9
- 230000035945 sensitivity Effects 0.000 description 9
- 230000035699 permeability Effects 0.000 description 8
- 239000002041 carbon nanotube Substances 0.000 description 7
- 238000000034 method Methods 0.000 description 7
- 230000029663 wound healing Effects 0.000 description 7
- 229910021393 carbon nanotube Inorganic materials 0.000 description 6
- 238000007650 screen-printing Methods 0.000 description 6
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 5
- 210000004027 cell Anatomy 0.000 description 5
- 239000000835 fiber Substances 0.000 description 5
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 5
- 239000002245 particle Substances 0.000 description 5
- 230000008569 process Effects 0.000 description 5
- 230000008859 change Effects 0.000 description 4
- 229910052739 hydrogen Inorganic materials 0.000 description 4
- 239000001257 hydrogen Substances 0.000 description 4
- 238000003756 stirring Methods 0.000 description 4
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 3
- 238000010521 absorption reaction Methods 0.000 description 3
- 230000000740 bleeding effect Effects 0.000 description 3
- 238000002073 fluorescence micrograph Methods 0.000 description 3
- 229910021389 graphene Inorganic materials 0.000 description 3
- 208000015181 infectious disease Diseases 0.000 description 3
- 239000002609 medium Substances 0.000 description 3
- 238000011056 performance test Methods 0.000 description 3
- 239000011148 porous material Substances 0.000 description 3
- 238000011084 recovery Methods 0.000 description 3
- 238000002560 therapeutic procedure Methods 0.000 description 3
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 2
- 239000006143 cell culture medium Substances 0.000 description 2
- 230000001684 chronic effect Effects 0.000 description 2
- 238000005034 decoration Methods 0.000 description 2
- 239000004205 dimethyl polysiloxane Substances 0.000 description 2
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 2
- 210000003743 erythrocyte Anatomy 0.000 description 2
- 230000035876 healing Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- CXQXSVUQTKDNFP-UHFFFAOYSA-N octamethyltrisiloxane Chemical compound C[Si](C)(C)O[Si](C)(C)O[Si](C)(C)C CXQXSVUQTKDNFP-UHFFFAOYSA-N 0.000 description 2
- 238000004987 plasma desorption mass spectroscopy Methods 0.000 description 2
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 2
- 230000007480 spreading Effects 0.000 description 2
- 238000003892 spreading Methods 0.000 description 2
- 241001391944 Commicarpus scandens Species 0.000 description 1
- 238000005033 Fourier transform infrared spectroscopy Methods 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- 206010072170 Skin wound Diseases 0.000 description 1
- 108090000190 Thrombin Proteins 0.000 description 1
- 238000002441 X-ray diffraction Methods 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 150000001450 anions Chemical class 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 231100000433 cytotoxic Toxicity 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 238000001523 electrospinning Methods 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 230000005182 global health Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 239000000017 hydrogel Substances 0.000 description 1
- 238000011068 loading method Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000004750 melt-blown nonwoven Substances 0.000 description 1
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Chemical compound C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 238000012806 monitoring device Methods 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- -1 polypropylene Polymers 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 238000001878 scanning electron micrograph Methods 0.000 description 1
- 229910052709 silver Inorganic materials 0.000 description 1
- 239000004332 silver Substances 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 230000003595 spectral effect Effects 0.000 description 1
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 238000009210 therapy by ultrasound Methods 0.000 description 1
- 229960004072 thrombin Drugs 0.000 description 1
- 238000002604 ultrasonography Methods 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
- 230000004580 weight loss Effects 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
- A61L15/28—Polysaccharides or their derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F13/00051—Accessories for dressings
- A61F13/00063—Accessories for dressings comprising medicaments or additives, e.g. odor control, PH control, debriding, antimicrobic
-
- A61F13/01012—
-
- A61F13/01017—
-
- A61F13/01029—
-
- A61F13/01038—
-
- A61F13/01046—
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F13/02—Adhesive plasters or dressings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F13/02—Adhesive plasters or dressings
- A61F13/0203—Adhesive plasters or dressings having a fluid handling member
- A61F13/0206—Adhesive plasters or dressings having a fluid handling member the fluid handling member being absorbent fibrous layer, e.g. woven or nonwoven absorbent pad, island dressings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F13/02—Adhesive plasters or dressings
- A61F13/0276—Apparatus or processes for manufacturing adhesive dressings or bandages
- A61F13/0286—Apparatus or processes for manufacturing adhesive dressings or bandages manufacturing of non adhesive dressings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
- A61L15/26—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/42—Use of materials characterised by their function or physical properties
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/42—Use of materials characterised by their function or physical properties
- A61L15/425—Porous materials, e.g. foams or sponges
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/42—Use of materials characterised by their function or physical properties
- A61L15/44—Medicaments
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/42—Use of materials characterised by their function or physical properties
- A61L15/56—Wetness-indicators or colourants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F2013/00089—Wound bandages
- A61F2013/00238—Wound bandages characterised by way of knitting or weaving
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
- A61L2300/23—Carbohydrates
- A61L2300/236—Glycosaminoglycans, e.g. heparin, hyaluronic acid, chondroitin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/418—Agents promoting blood coagulation, blood-clotting agents, embolising agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2400/00—Materials characterised by their function or physical properties
- A61L2400/04—Materials for stopping bleeding
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2400/00—Materials characterised by their function or physical properties
- A61L2400/12—Nanosized materials, e.g. nanofibres, nanoparticles, nanowires, nanotubes; Nanostructured surfaces
Abstract
The invention relates to the technical field of wound dressings, in particular to an intelligent wound dressing, a preparation method and application thereof and a flexible sensor. The invention provides an intelligent wound dressing which comprises a substrate and a functional layer arranged on the surface of the substrate; the substrate is chitosan hemostatic sponge; the functional layer is a citric acid-thermoplastic elastomer polyurethane composite nanofiber membrane. The intelligent wound dressing has good responsiveness to humidity and pressure.
Description
Technical Field
The invention relates to the technical field of wound dressings, in particular to an intelligent wound dressing, a preparation method and application thereof and a flexible sensor.
Background
Pathogenic infections have become a global health care challenge as the most common complication of chronic wounds, and detection of wound healing processes has become of particular importance. Currently, dressings in the form of films, sponges and hydrogels are the main choice for clinical wound treatment. However, current wound dressings are essentially passive therapies, making it difficult to achieve both actual wound therapy and the need for dynamic healing monitoring of chronic wounds. Therefore, there is a great need for an intelligent wound dressing system to enable real-time monitoring of wound healing status and on-demand therapy. With the advent of the internet of things and smart wearable devices, new generation smart wound dressings with smart wearable sensors as the core can solve the above problems faced by current wound dressings by detecting physicochemical signals related to the wound healing process. Among them, wound moisture, which is closely related to the verification of the wound site and the infection state, and the change in the pressure value of the surrounding skin during the wound healing process are considered as the most important and promising monitoring indexes.
Disclosure of Invention
The invention aims to provide an intelligent wound dressing, a preparation method and application thereof and a flexible sensor. The intelligent wound dressing has good responsiveness to humidity and pressure.
In order to achieve the above object, the present invention provides the following technical solutions:
the invention provides an intelligent wound dressing which comprises a substrate and a functional layer arranged on the surface of the substrate;
the substrate is chitosan hemostatic sponge;
the functional layer is a citric acid-thermoplastic elastomer polyurethane composite nanofiber membrane.
Preferably, the mass ratio of the citric acid to the thermoplastic elastomer polyurethane in the citric acid-thermoplastic elastomer polyurethane composite nanofiber membrane is (0.05-0.15): 1.
the invention also provides a preparation method of the intelligent wound dressing, which comprises the following steps:
mixing citric acid, thermoplastic elastomer polyurethane and a solvent to obtain a composite spinning solution;
and (3) performing electrostatic spinning on the composite spinning solution by taking chitosan hemostatic sponge as a substrate to obtain the intelligent wound dressing.
Preferably, the mass concentration of the thermoplastic elastomer polyurethane in the composite spinning solution is 15-30%.
Preferably, the mass ratio of the citric acid to the thermoplastic elastomer polyurethane is (0.05-0.15): 1.
preferably, the solvent comprises N, N-dimethylformamide and tetrahydrofuran;
the volume ratio of the N, N-dimethylformamide to the tetrahydrofuran is (0.5-2.5): 1.
preferably, the electrostatic spinning adopts 2-4 nozzle spinning;
the temperature of the electrostatic spinning is 30-50 ℃, the positive voltage is 10-24 kV, the negative voltage is-5 to-1 kV, the time is 1-5 h, the propelling speed is 1-3 mL/h, and the receiving distance is 10-18 cm.
The invention also provides application of the intelligent wound dressing in the technical scheme or the intelligent wound dressing prepared by the preparation method in the technical scheme in the field of intelligent wound monitoring.
The invention also provides a flexible sensor for wound intelligent monitoring, which comprises the intelligent wound dressing in the technical scheme or the intelligent wound dressing prepared by the preparation method in the technical scheme and an electrode layer arranged on the surface of the functional layer in the intelligent wound dressing.
Preferably, the thickness of the electrode layer is 50 to 60nm.
The invention provides an intelligent wound dressing which comprises a substrate and a functional layer arranged on the surface of the substrate; the substrate is chitosan hemostatic sponge; the functional layer is a citric acid-thermoplastic elastomer polyurethane composite nanofiber membrane.
Compared with the prior art, the invention has the following advantages:
1) Hydroxyl and carboxyl in the citric acid easily form a hydrogen bond connected network structure, the hydroxyl exposed on the surface of the citric acid can form a hydrogen bond with external water molecules, three carboxyl groups contained in the citric acid can also form intermolecular hydrogen bonds with the water molecules, and the ultrahigh humidity response sensitivity can be achieved by adding the hydroxyl and the carboxyl into a nanofiber membrane;
2) The nano-fiber membrane structure is characterized in that nano-fibers under the microcosmic condition are arranged in a staggered mode, and a microstructure with an uneven surface is constructed in the functional layer, so that the sensitivity and the response time of the microstructure can be effectively improved; meanwhile, the citric acid-thermoplastic elastomer polyurethane composite nanofiber membrane has the characteristics of softness, stretchability and air permeability, has good biocompatibility, can not cause damage to human bodies when used on human skins, can be combined with chitosan hemostatic sponge to form a wound dressing for intelligently monitoring the healing condition of open wounds, has a hemostatic effect on the wounds, and is used for monitoring the health of the open wounds;
3) The intelligent wound dressing can be used as an early prediction index of pathological infection by detecting the humidity and pressure change of the wound in real time and judging the wound healing condition;
4) The chitosan hemostatic sponge has water-absorbing expansion performance, can rapidly absorb water in blood to stop bleeding, can agglutinate red blood cells by combining polycation of chitosan with anions on the surface of a red blood cell membrane, and simultaneously activates platelet aggregation and thrombin, thereby achieving the purpose of rapid hemostasis; has solubility, and can form uniform chitosan gel layer on the surface of bleeding wound to protect the surface of wound and stop bleeding.
Drawings
Fig. 1 is an SEM image of a functional layer in the smart wound dressings prepared in examples 1 to 3 and comparative example 1;
fig. 2 is an XRD pattern of the functional layers in the smart wound dressings prepared in examples 1 to 3 and comparative example 1;
FIG. 3 is a FT-TR graph of the functional layer and pure CA in the smart wound dressings prepared in examples 1-3 and comparative example 1;
fig. 4 is a TG curve of the functional layer in the intelligent wound dressings prepared in examples 1 to 3 and comparative example 1;
FIG. 5 shows the mechanical property test results of the functional layers in the intelligent wound dressings prepared in examples 1 to 3 and comparative example 1;
fig. 6 is a water contact angle test result of the functional layer in the smart wound dressings prepared in examples 1 to 3 and comparative example 1;
fig. 7 is a result of biocompatibility testing of a functional layer in the smart wound dressing prepared in example 3;
FIG. 8 is a humidity response performance test result of the flexible sensor according to examples 4-6;
FIG. 9 shows the results of the pressure response performance test of the flexible sensor according to example 6;
FIG. 10 shows the results of the permeability test of the flexible sensor according to example 6.
Detailed Description
The invention provides an intelligent wound dressing which comprises a substrate and a functional layer arranged on the surface of the substrate;
the substrate is chitosan hemostatic sponge;
the functional layer is a citric acid-thermoplastic elastomer polyurethane composite nanofiber membrane.
In the present invention, the thickness of the chitosan hemostatic sponge is preferably 0.5 to 3mm, more preferably 1 to 2mm, and most preferably 1.8mm.
In the present invention, the thickness of the functional layer is preferably 30 to 60 μm, more preferably 35 to 50 μm, and most preferably 44 μm.
In the present invention, the mass ratio of citric acid to thermoplastic elastomer polyurethane in the citric acid-thermoplastic elastomer polyurethane composite nanofiber membrane is preferably (0.05 to 0.15): 1, more preferably (0.10 to 0.15): 1.
the invention also provides a preparation method of the intelligent wound dressing, which comprises the following steps:
mixing Citric Acid (CA), thermoplastic elastomer polyurethane (TPU) and a solvent to obtain a composite spinning solution;
and performing electrostatic spinning on the composite spinning solution by taking chitosan hemostatic sponge as a substrate to obtain the intelligent wound dressing.
In the present invention, all the starting materials for the preparation are commercially available products well known to those skilled in the art, unless otherwise specified.
According to the invention, citric acid, thermoplastic elastomer polyurethane and a solvent are mixed to obtain a composite spinning solution.
In the present invention, the solvent preferably includes N, N-dimethylformamide and tetrahydrofuran; the volume ratio of the N, N-dimethylformamide to the tetrahydrofuran is preferably (0.5 to 2.5): 1, more preferably 1.
In the present invention, the mass concentration of the thermoplastic elastomer polyurethane in the composite spinning solution is preferably 15 to 30%, more preferably 18 to 26%, and most preferably 20 to 23%.
In the present invention, the mass ratio of the citric acid to the thermoplastic elastomer polyurethane is preferably (0.05 to 0.15): 1, more preferably (0.10 to 0.15): 1.
in the present invention, the mixing is preferably performed by mixing citric acid and a solvent under ultrasonic conditions, adding a thermoplastic elastomer polyurethane, and stirring and mixing. In the invention, the power of the ultrasound is preferably 400W, and the time is preferably 15min; the stirring and mixing conditions are not particularly limited in the present invention, and the stirring and mixing conditions are well known to those skilled in the art, and the obtained composite spinning solution is uniformly mixed.
After the composite spinning solution is obtained, the chitosan hemostatic sponge is used as a substrate, and the composite spinning solution is subjected to electrostatic spinning to obtain the intelligent wound dressing.
In the present invention, the electrospinning preferably employs 2 to 4-nozzle spinning. The temperature of the electrostatic spinning is preferably 30-50 ℃, more preferably 35-45 ℃, and most preferably 38-42 ℃; the positive voltage is preferably 10 to 24kV, more preferably 13 to 20kV, and most preferably 15 to 18kV; the negative voltage is preferably-5 to-1 kV, more preferably-4 to-2 kV; the time is preferably 1 to 5 hours, more preferably 2 to 4 hours, and most preferably 2.5 to 3.5 hours; the propelling speed is preferably 1-3 mL/h, more preferably 1.5-2.5 mL/h, and most preferably 1.8-2.2 mL/h; the receiving distance is preferably 10 to 18cm, more preferably 12 to 16cm, most preferably 13 to 15cm.
The invention also provides application of the intelligent wound dressing in the technical scheme or the intelligent wound dressing prepared by the preparation method in the technical scheme in the field of intelligent wound monitoring.
The invention also provides a flexible sensor for wound intelligent monitoring, which comprises the intelligent wound dressing in the technical scheme or the intelligent wound dressing prepared by the preparation method in the technical scheme and an electrode layer arranged on the surface of the functional layer in the intelligent wound dressing.
In the present invention, the electrode layer is a mesh structure.
In the present invention, the thickness of the electrode layer is preferably 50 to 60nm, and more preferably 53 to 56nm.
In the present invention, the material of the electrode layer preferably includes one or more of silver, carbon nanotubes, and graphene.
In the present invention, the electrode layer is preferably replaced with a conductive patch.
In the present invention, the flexible sensor further preferably includes a wire; the lead is connected with two opposite sides of the electrode layer; the wire is preferably a copper wire.
In the present invention, the flexible sensor is preferably electrically connected to a monitoring device in use.
In the present invention, the method for manufacturing the flexible sensor preferably includes the steps of:
preparing an intelligent wound dressing;
preparing an electrode layer on the surface of a functional layer in the intelligent wound dressing by adopting a screen printing mode, and connecting wires on two opposite sides of the electrode layer to obtain the flexible sensor;
or after a layer of conductive paste is pasted on the surface of the functional layer in the intelligent wound dressing, connecting wires on two opposite sides of the electrode layer to obtain the flexible sensor.
In the present invention, the method for preparing the intelligent wound dressing is preferably performed by using the preparation method described in the above technical scheme, and details are not repeated herein.
After the intelligent wound dressing is obtained, an electrode layer is prepared on the surface of a functional layer in the intelligent wound dressing in a screen printing mode, and the flexible sensor is obtained.
In the present invention, the preparation process of the electrode layer preferably includes:
providing a conductive ink;
and covering a screen printing plate on the functional layer, pouring the conductive ink on the screen printing plate, pushing the conductive ink away and spreading by using a scraper blade, and airing to obtain the electrode layer.
In the present invention, the conductive ink is preferably one or more of a conductive silver paste, a carbon nanotube-containing ink and a graphene-containing ink, and the present invention does not have any particular limitation on the composition of the conductive silver paste, the carbon nanotube-containing ink and the graphene-containing ink, and may adopt commercially available products well known to those skilled in the art.
The intelligent wound dressing, the preparation method and application thereof, and the flexible sensor provided by the present invention are described in detail with reference to the following examples, but they should not be construed as limiting the scope of the present invention.
Example 1
Mixing 0.25g of CA with 20mL of a mixed solution of N, N-dimethylformamide and tetrahydrofuran in a volume ratio of 1, performing ultrasonic treatment at 400W for 15min, adding 5g of TPU, and stirring until the TPU is completely dissolved to obtain a composite spinning solution;
transferring the composite spinning solution into two 10mL injectors, installing the injectors on a spinning machine, attaching chitosan hemostatic sponge serving as a substrate to a receiving roller of the spinning machine, and adjusting spinning conditions (the temperature is 30 ℃, the positive voltage is 18kV, the negative voltage is 2kV, the time is 3h, the propelling speed is 1mL/h, and the receiving distance is 10 cm) to obtain the intelligent wound dressing (the mass ratio of citric acid to thermoplastic elastomer polyurethane in the functional layer is 0.05.
Example 2
With reference to example 1, except that the amount of CA was 0.5g, an intelligent wound dressing was prepared (mass ratio of citric acid to thermoplastic elastomer polyurethane in the functional layer 0.1, noted CA/TPU-10%).
Example 3
Referring to example 1, except that the amount of CA was 0.75g, a smart wound dressing was prepared (mass ratio of citric acid to thermoplastic elastomer polyurethane in the functional layer 0.15, noted CA/TPU-15%).
Example 4
Covering a screen printing plate on the surface of the functional layer in the embodiment 1, pouring carbon nanotube ink on the screen printing plate, pushing the conductive ink away and flatly spreading by using a scraper, and naturally airing to obtain the electrode layer;
conductive copper wires were bonded to opposite ends of the electrode layer to yield a flexible sensor (noted CTHPS-5%).
Example 5
Referring to example 4, except that an electrode layer was prepared on the surface of the functional layer described in example 2, a flexible sensor (noted as CTHPS-10%) was obtained.
Example 6
Referring to example 4, except that an electrode layer was prepared on the surface of the functional layer described in example 3, a flexible sensor (noted as CTHPS-15%) was obtained.
Comparative example 1
Reference is made to example 1, the only difference being that no CA is added.
Test example
SEM tests were performed on the functional layers in the intelligent wound dressings prepared in examples 1 to 3 and comparative example 1, and the test results are shown in fig. 1, in which (a) corresponds to comparative example 1, (b) corresponds to example 1, (c) corresponds to example 2, and (d) corresponds to example 3; as can be seen from FIG. 1, the functional layer fibers without CA addition in comparative example 1 were smooth and continuous and had uniform diameter distribution (average diameter of about 582. + -. 7.2 nm), forming a three-dimensionally arranged lattice structure; in example 1, a small amount of CA particles are loaded on the surface of the fiber, and with the increase of the addition amount of CA, the loading amount of the CA particles on the surface of the citric acid/thermoplastic elastomer polyurethane (CA/TPU) composite nanofiber is increased, and the CA particles are distributed uniformly, and in addition, as the addition amount of CA is increased, the surface tension required to be overcome in the electrostatic spinning process is reduced, so that the diameter of the fiber is reduced to 525 ± 6.5nm, and thus more microstructures are formed in the film, which is beneficial to improving the humidity and pressure sensing performance of the fiber film;
XRD tests are carried out on the functional layers in the intelligent wound dressings prepared by the embodiments 1-3 and the comparative example 1 (pure TPU), the test results are shown in figure 2, XRD spectral lines of CA/TPU-5% and CA/TPU-10% are basically consistent with those of the pure TPU, and therefore, the fact that the crystal structure of the TPU is not changed obviously by doping of CA is inferred. And with the increase of the doping amount, the characteristic diffraction peak of the CA particles in XRD is more obvious, which shows that the CA particles are successfully doped into the TPU nanofiber membrane;
FT-TR test was performed on the functional layer and pure CA in the intelligent wound dressings prepared in examples 1 to 3 and comparative example 1, and the test result is shown in FIG. 3, and it can be seen from FIG. 3 that pure TPU is 3000cm -1 And 1750cm -1 The peak values are respectively-N-H-stretching vibration absorption peak and C ≡ O stretching vibration absorption peak, which are very obvious in FT-IR of the CA/TPU composite nanofiber membrane, and the basic structure of the TPU can not be damaged by blending electrostatic spinning of the TPU and the CA. In addition, the thickness is 1736-1720 cm -1 A new absorption band appears in the CA/TPU composite nanofiber membrane, is a C = O stretching vibration peak and belongs to a characteristic peak of CA, and the fact that the TPU membrane successfully loads CA is proved;
the functional layers in the intelligent wound dressings prepared in examples 1 to 3 and comparative example 1 (pure TPU) were TG tested, and the test results are shown in fig. 4, and it can be seen from fig. 4 that pure TPU and all CA/TPU composite nanofiber films have a small weight loss due to the loss of adsorbed water when the temperature is below 200 ℃. Between 200 and 450 ℃, pure TPU and CA/TPU composite nanofiber membranes show severe mass loss due to decomposition of the polymer. With the increase of the doping amount of CA, the residual mass percentage of the CA/TPU composite nanofiber membrane is increased, and the residual weight of the CA/TPU-15% is 10.5%, which indicates that CA is successfully doped into TPU;
the functional layers in the intelligent wound dressings prepared in examples 1 to 3 and comparative example 1 (pure TPU) were subjected to mechanical property tests, and the stress-strain curve is shown in fig. 5, and it can be seen from fig. 5 that the ultimate stress monotonically increases from 0.7MPa to 1.3MPa as the CA content increases from 0 to 10 wt%. When the doping amount of CA is 15%, the tensile strain of the CA/TPU composite nanofiber membrane is about 350%, and the elongation at break is about 450%. The tensile strain of the CA/TPU composite nanofiber membrane is always kept above 350%, and the elongation at break is also kept at a higher level (about 470%), which shows that the CA/TPU nanofiber membrane has good flexibility and stretchability, and is not easy to break when attached to the skin;
the functional layers in the intelligent wound dressings prepared in examples 1 to 3 and comparative example 1 (pure TPU) were subjected to a water contact angle test, and the test result is shown in fig. 6, as can be seen from fig. 6, the water contact angle of comparative example 1 is 132 °, the water contact angles of examples 1 to 3 are 72 °, 57 ° and 46 °, respectively, and thus it can be seen that the water contact angle of the composite nanofiber membrane doped with CA is reduced, which indicates that the wettability of the composite nanofiber membrane is improved by the addition of CA, and the hydrophilic property of the composite nanofiber membrane is enhanced. The CA molecules contain a plurality of carboxyl and hydroxyl groups, and the carboxyl and the hydroxyl groups can form intermolecular hydrogen bonds with water molecules in the air, so that the water molecules are adsorbed on the surface of the nanofiber membrane in a physical adsorption mode and are the basis of humidity response;
the functional layer in the intelligent wound dressing prepared in example 3 was subjected to a biocompatibility test, and the test results are shown in fig. 7, where (a) is a fluorescence image of HaCaT cells cultured on a Roswell Park Memorial Institute-1640 standard medium for 4 days, (b) is a fluorescence image of HaCaT cells cultured on the functional layer in the intelligent wound dressing prepared in example 3, (c) is a fluorescence image of HaCaT cells cultured on a blank cell culture medium, and (d) is an OD value of HaCaT cells cultured on a Roswell Park Memorial Institute-1640 standard medium, the functional layer in the intelligent wound dressing prepared in example 3, and the cell culture medium for different blank times, respectively, and it can be seen from fig. 7 that the functional layer in the intelligent wound dressing prepared in example 3 has no significant cytotoxicity effect on HaCaT a wavelength of 450nm, and the cell survival rate is measured after culturing on the functional layer in the intelligent wound dressing prepared in example 3 for 4 days, and the absorbance at a wavelength of 450nm is not significantly reduced. The functional layer in the intelligent wound dressing prepared in example 3 is biocompatible and can be directly used on the skin or open wounds;
the humidity response performance of the flexible sensors described in examples 4 to 6 was tested, and the test results are shown in fig. 8, wherein (a) is a humidity-relative resistance change curve of the flexible sensors described in examples 4 to 6 at 20 to 90 RH, and (b) is a hysteresis curve of the flexible sensors described in example 6 at 20 to 90 RH, and from (a), it was found that the relative resistance of the flexible sensors increased with increasing humidity, and in the low humidity range (20 to 50 RH), the humidity sensitivity of the flexible sensors was approximately the same as 0.6 RH, and in the high humidity range (50% to 90% RH), the CTHPS-15% humidity sensitivity was the highest and was approximately 2.15% RH, while CTHPS-5% and CTHPS-10% were respectively 1.32/% RH and 1.88%/RH. Therefore, as the doping amount of CA is increased, the humidity sensing performance of the flexible sensor is enhanced, so that the optimal doping amount of CA is 15%; from (b), the humidity hysteresis of CTHPS-15% was 10% in the humidity range of 20% -90% RH, demonstrating good stability of the sensor over a wide humidity range;
the flexible sensor of example 6 was subjected to a pressure response performance test, and the test results are shown in fig. 9, in which (a) is a pressure sensitivity curve, (b) is a time response curve, and (c) is a response recovery curve; as can be seen from (a), the pressure sensitivity is divided into three linear regions: s in the low pressure range (0 to 2.25 kPa) P1 S in the medium pressure range (2.25 to 11.25 kPa) P2 And S in a high pressure range (11.25 to 26.25 kPa) P3 . CTHPS-15% vs S P1 、S P2 And S P3 Sensitivity of 10.53, 2.56 and 0.3kPa, respectively -1 The inside of the electrospun nanofiber membrane has a large number of pores and gaps. The presence of pores and gaps results in poor contact between the conductive CNTs, resulting in a large initial resistance of the CTHPS without applying pressure, and once pressure is applied to the sensor, compressive deformation occurs, the pores and gaps between the nanofibers decrease, the contact between the fibers and the conductive carbon nanotubes increases greatly, and when a small pressure (0 to 2) is applied25 kPa), the carbon nanotube electrode comes into closer contact with the nanofiber membrane, resulting in a sharp increase in conductivity, at which the sensitivity is higher. When the applied pressure is increased (2.25-11.25 kPa), the layers of nanofibers are tightly compressed together, resulting in a further increase in conductivity and a decrease in resistance. According to clinical data, the pressure value of the open wound of the human abdomen is usually lower than 10kPa, therefore, CTHPS can be used for open intelligent wound dressing, and the wound healing degree is monitored according to the pressure value change of the surrounding skin in the wound healing process. As the pressure increased (11.25-26.25 kPa), the sensitivity of the sensor decreased to 0.3kPa -1 . This is because the mutual contact of the conductive carbon nanotubes cannot be improved, and the output resistance hardly changes; as can be seen from (b), CTHPS-15% exhibits a fast response (88 ms) and a recovery time (90 ms), indicating that the sensor has a fast response; from (c), the response recovery curve of CTHPS-15% under 200 times of cycle test shows that the sensor has good cycle stability;
the air permeability test of the flexible sensor described in example 6, the TPU nanofiber membrane described in comparative example 1, and the PDMS membrane was performed, and the test result is shown in fig. 10, and it can be seen from fig. 10 that the air permeability of the TPU nanofiber membrane was 192mm/s, which is superior to that of the PDMS membrane (0 mm/s) commonly used in the flexible pressure sensor, and similar to that of the polypropylene melt-blown nonwoven fabric (air permeability of about 198 mm/s) used as a filter in the medical protective mask. The permeability of CTHPS-15% was 171mm/s, which was slightly less than that of pure TPU, but still exhibited good permeability, indicating excellent permeability of CTHPS-15%.
The foregoing is only a preferred embodiment of the present invention, and it should be noted that, for those skilled in the art, various modifications and decorations can be made without departing from the principle of the present invention, and these modifications and decorations should also be regarded as the protection scope of the present invention.
Claims (8)
1. A flexible sensor for wound intelligent monitoring is characterized by comprising an intelligent wound dressing and an electrode layer arranged on the surface of a functional layer in the intelligent wound dressing;
the intelligent wound dressing comprises a substrate and a functional layer arranged on the surface of the substrate;
the substrate is chitosan hemostatic sponge;
the functional layer is a citric acid-thermoplastic elastomer polyurethane composite nanofiber membrane.
2. The flexible sensor of claim 1, wherein the mass ratio of the citric acid to the thermoplastic elastomer polyurethane in the citric acid-thermoplastic elastomer polyurethane composite nanofiber membrane is (0.05 to 0.15): 1.
3. the flexible sensor of claim 1 or 2, wherein the method of making the intelligent wound dressing comprises the steps of:
mixing citric acid, thermoplastic elastomer polyurethane and a solvent to obtain a composite spinning solution;
and (3) performing electrostatic spinning on the composite spinning solution by taking chitosan hemostatic sponge as a substrate to obtain the intelligent wound dressing.
4. The flexible sensor according to claim 3, wherein the mass concentration of the thermoplastic elastomer polyurethane in the composite spinning solution is 15 to 30%.
5. The flexible sensor according to claim 3 or 4, wherein the mass ratio of the citric acid to the thermoplastic elastomer polyurethane is (0.05 to 0.15): 1.
6. the flexible sensor of claim 5, wherein the solvent comprises N, N-dimethylformamide and tetrahydrofuran;
the volume ratio of the N, N-dimethylformamide to the tetrahydrofuran is (0.5-2.5): 1.
7. the flexible sensor according to claim 3, wherein the electrostatic spinning is performed by using 2 to 4 nozzles;
the electrostatic spinning temperature is 30 to 50 ℃, the positive voltage is 10 to 24kV, the negative voltage is-5 to-1 kV, the time is 1 to 5h, the propelling speed is 1 to 3mL/h, and the receiving distance is 10 to 18cm.
8. The flexible sensor according to claim 1, wherein the thickness of the electrode layer is 50 to 60nm.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210371111.8A CN114618006B (en) | 2022-04-11 | 2022-04-11 | Intelligent wound dressing, preparation method and application thereof, and flexible sensor |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210371111.8A CN114618006B (en) | 2022-04-11 | 2022-04-11 | Intelligent wound dressing, preparation method and application thereof, and flexible sensor |
Publications (2)
Publication Number | Publication Date |
---|---|
CN114618006A CN114618006A (en) | 2022-06-14 |
CN114618006B true CN114618006B (en) | 2022-11-25 |
Family
ID=81905134
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202210371111.8A Active CN114618006B (en) | 2022-04-11 | 2022-04-11 | Intelligent wound dressing, preparation method and application thereof, and flexible sensor |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN114618006B (en) |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103920179A (en) * | 2014-04-22 | 2014-07-16 | 楚立云 | Graphene wound dressing |
CN104189945A (en) * | 2014-09-29 | 2014-12-10 | 福州大学 | Double-layered composite biological dressing and adhesive-free compound technology thereof |
CN105497969A (en) * | 2014-09-26 | 2016-04-20 | 理大产学研基地(深圳)有限公司 | Multilayer composite film dressing and preparation method thereof |
CN209437726U (en) * | 2018-10-15 | 2019-09-27 | 湖北省百纳慧喻生物科技有限公司 | A kind of quaternized chitin lamination antiseptic dressing |
CN111768895A (en) * | 2020-07-06 | 2020-10-13 | 东华大学 | Air-permeable transparent flexible fiber-based surface electrode and preparation method thereof |
CN113952114A (en) * | 2021-09-24 | 2022-01-21 | 北京科技大学 | Multilayered nanofiber dressing with patterned releasable gas and method of making same |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6693180B2 (en) * | 2002-04-04 | 2004-02-17 | China Textile Institute | Composite sponge wound dressing made of β-Chitin and Chitosan and method for producing the same |
-
2022
- 2022-04-11 CN CN202210371111.8A patent/CN114618006B/en active Active
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103920179A (en) * | 2014-04-22 | 2014-07-16 | 楚立云 | Graphene wound dressing |
CN105497969A (en) * | 2014-09-26 | 2016-04-20 | 理大产学研基地(深圳)有限公司 | Multilayer composite film dressing and preparation method thereof |
CN104189945A (en) * | 2014-09-29 | 2014-12-10 | 福州大学 | Double-layered composite biological dressing and adhesive-free compound technology thereof |
CN209437726U (en) * | 2018-10-15 | 2019-09-27 | 湖北省百纳慧喻生物科技有限公司 | A kind of quaternized chitin lamination antiseptic dressing |
CN111768895A (en) * | 2020-07-06 | 2020-10-13 | 东华大学 | Air-permeable transparent flexible fiber-based surface electrode and preparation method thereof |
CN113952114A (en) * | 2021-09-24 | 2022-01-21 | 北京科技大学 | Multilayered nanofiber dressing with patterned releasable gas and method of making same |
Non-Patent Citations (3)
Title |
---|
PA6/CA复合纳米纤维膜的制备及调湿性能研究;张佳敏等;《北京服装学院学报(自然科学版)》;20191230(第04期);第19-23页 * |
可调制润湿性和力学性能的电纺纤维膜的制备与性能研究;黄博能等;《高分子学报》;20120920(第09期);第929页左栏第1段、第930页左栏第1段、第935页右栏第1段 * |
纳米纤维膜基柔性压力传感器的优化设计制备;王杰等;《纺织学报》;20191130;第40卷(第11期);第32-37页 * |
Also Published As
Publication number | Publication date |
---|---|
CN114618006A (en) | 2022-06-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Naseri et al. | Electrospun chitosan-based nanocomposite mats reinforced with chitin nanocrystals for wound dressing | |
CN107376000B (en) | Microfibre state hemostatic material and preparation method thereof and hemostatic article | |
CN107823693B (en) | Stanch fibre film and preparation method thereof and hemostatic article | |
CN107823692B (en) | Wound dressing composite nanofiber membrane and preparation method thereof | |
Zhao et al. | Rational design of high-performance wearable tactile sensors utilizing bioinspired structures/functions, natural biopolymers, and biomimetic strategies | |
CN111001042B (en) | Completely degradable tissue engineering skin scaffold material and preparation method thereof | |
CN111493863B (en) | Air-permeable antibacterial electrode plate and preparation method thereof | |
CN112812332A (en) | Collagen fiber-based flexible pressure sensing material and preparation method thereof | |
You et al. | Flexible porous Gelatin/Polypyrrole/Reduction graphene oxide organohydrogel for wearable electronics | |
Yin et al. | Electrospun micro/nanofiber with various structures and functions for wearable physical sensors | |
Yao et al. | Preparation and properties of electrospun peanut protein isolate/poly-l-lactic acid nanofibers | |
Shen et al. | Cellulose gel mechanoreceptors–principles, applications and prospects | |
CN114618006B (en) | Intelligent wound dressing, preparation method and application thereof, and flexible sensor | |
Lee et al. | Macroscopic assembly of sericin toward self-healable silk | |
KR101033278B1 (en) | Improved preparation method of PVA nanofiber membrane using electrospinning | |
KR20100133117A (en) | Nanofiber for dressing, dressing composite using the same, and method of manufacturing the same | |
Yan et al. | Highly breathable, surface-hydrophobic and wet-adhesive silk based epidermal electrode for long-term electrophysiological monitoring | |
WO2021197462A1 (en) | Elastic conductor composite film and preparation method therefor | |
CN110841102B (en) | Composite nanofiber elastic bandage and preparation method thereof | |
CN114164562A (en) | PCL/ZnO-CSLE/PLA double-layer nanofiber membrane, and preparation method and application thereof | |
EP3415170B1 (en) | Sheet for covering wound | |
CN116217969B (en) | Bacterial cellulose composite hydrogel and preparation method thereof | |
CN108026313A (en) | The electrode of polymer composition and device for bioelectrical signals non-invasive measurement | |
CN116077350A (en) | Electrospinning composite nanofiber membrane, preparation method and application | |
CN114989550A (en) | GO/AgNPs conductive hydrogel, preparation method and application thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |